查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球临床实验室服务市场：依检测类型、地点、产品和国家的策略和趋势预测 - 附执行顾问指南 - 第8阿宿版（2025-2029年）
市场调查报告书
商品编码
1764337

全球临床实验室服务市场：依检测类型、地点、产品和国家的策略和趋势预测 - 附执行顾问指南 - 第8阿宿版（2025-2029年）

Global Clinical Medical Laboratory Services Market. Strategy & Trends with Forecasts by Assay Type, by Place, by Product, and by Country. Situation Analysis with Executive & Consultant Guides - 8th Edition. 2025 to 2029
出版日期: | 出版商: Howe Sound Research | 英文 373 Pages | 商品交期: 最快1-2个工作天内

价格

临床实验室积极应对新冠疫情的挑战，但疫情的结束也催生了新的诊断方法。即时检验和自我检测威胁临床实验室服务的长期需求，而分子诊断则推动其快速成长。阅读这份全面的报告，了解其中的机会和威胁。

生物技术，尤其是基因体学的爆炸性发展将直接惠及临床检测。各种动态趋势推动市场成长和公司估值。

本报告提供的资料可供分析师和规划人员使用。报告详细细分了15个国家和4个地区。购买本报告的用户均可查看全球任何国家的详细资料。

所有报告资料可依需求提供 Excel 格式。

目录

第1章 市场指南

  • 策略情势分析
  • 高阶主管、行销、销售和业务开发人员指南
  • 管理顾问和投资顾问指南

第2章 简介与市场定义

  • 新兴的临床检测需求
  • 机会定义
    • 市场收入规模
  • 研究方法
  • 视角：医疗保健和体外诊断（IVD）行业

第3章 市场动态概览

  • 市场参与者
    • 学术研究机构
    • 诊断侦测开发商
    • 仪器供应商
    • 药品和试剂製造商
    • 病理供应商
    • 独立临床实验室
    • 公共国家/地区实验室
    • 医院实验室
    • 临床实验室
    • 审核机构
    • 认证机构
  • 细分－各种方法
    • 传统市场细分
    • 实验室重点及细分
  • 临床检测产业结构
    • 医院实验室的市场占有率
    • 规模经济的关键作用
    • 医院实验室的存在
    • 医师与即时检验（POCT）—中国病患服务的復苏
  • 国家和地区多样性

第4章 驱动市场变化的趋势

  • 成长受到多种因素的推动
    • 人口结构对消费的影响
    • 新冠疫情相关影响
    • 即时检验带来变革
    • 替代医学的影响
    • Esoterics
    • 新的实验领域
  • 市场萎缩的驱动因素
    • 成本去向
    • 人口结构的影响
    • 管理实践
    • 健康
    • 同类相食
    • 即时检定
  • 自动化和实验室的趋势
    • 传统的自动化与集中化
    • 新的自动化、分散化和即时检验
    • 仪器是市场占有率的关键
    • 生物资讯学发挥重要作用角色
    • PCR 占据主导地位
    • 新一代定序推动变革
    • NGS 的价格影响
    • 全基因组定序，一个美丽新世界
    • 伴随诊断模糊了诊断和治疗的界限
    • 诊断的角色转变

第5章 临床检测服务的最新趋势

第6章 主要公司简介

  • Accel Diagnostics
  • Acibadem Labmed Laboratory
  • ACM Medical Laboratory
  • Adicon Clinical Laboratories
  • Aegis Science Corporation
  • American Bio-Clinical Laboratories, Int'l
  • ARUP Laboratories
  • Ascend Clinical
  • Bio-Reference Laboratories
  • Bioscientia Institut fur Medizinische Diagnostik GmbH
  • BP Healthcare Group
  • C2N Diagnostics
  • Clinical Reference Laboratory
  • Clongen Laboratories
  • CompuNet Clinical Laboratories
  • DASA
  • DIAN Diagnostics Co., Ltd.
  • Enzo Biochem
  • Eone Laboratories
  • Eurofins Scientific
  • Exagen Diagnostics
  • Flow Health
  • Fyr Diagnostics
  • Genzyme Corporation
  • Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • Haystack Oncology（Quest Dx）
  • Innoquest Pathology
  • Integrated Regional Laboratories
  • KDL Group
  • Laboratory Corporation of America
  • Lifelabs（Quest）
  • Mayo Clinic Laboratories
  • Medicover
  • Myriad Genetics
  • NeoGenomics
  • OncoDNA
  • Oncohost
  • Prometheus Laboratories
  • ProPhase Labs
  • Psychemedics Corporation
  • Quest Diagnostics
  • SkylineDx
  • Sonic Healthcare
  • Sophia Genetics
  • Spectra Laboratories
  • Streamline Scientific
  • Synlab
  • Sysmex Inostics
  • Unilabs
  • Werfen

第7章 全球临床实验室诊断市场

  • 依国家全球市场概览
  • 依检测类型全球市场概览
  • 依地区全球市场概览
  • 依产品全球市场概览

第8章 全球临床实验室诊断市场类型 - 依检测类型

  • 化学
  • 微生物学
  • 血液学
  • 解剖病理学
  • 分子诊断学
  • 深奥测试

第9章 全球临床实验室诊断市场 - 依地区

  • 住院医院
  • 门诊医院
  • 独立实验室
  • 医院实验室
  • 其他

第10章 全球临床实验室诊断市场 - 依产品

  • 设备
  • 试剂
  • 人事费用
  • 间接费用
  • 其他

第11章 临床实验室的未来

第12章 附录

  • 美国医疗保险系统：临床实验室收费表
  • 最常用的体外诊断试剂检测
  • 最赚钱的试剂检测

The Clinical Laboratory rose to the COVID challenge, but the end of the pandemic has created a new approach to diagnostics. Point of Care and Self Testing are threatening long term demand for clinical lab services but Molecular Diagnostics is driving runaway growth. Understand the opportunities and the threats in this comprehensive report.

The fundamentals are still here. Clinical laboratory testing is positioned to directly benefit from the explosion in biotechnology, especially genomics. A range of dynamic trends are pushing market growth and company valuations.

The report provides data that analysts and planners can use. The report includes detailed breakouts for 15 Countries and 4 Regions. A detailed breakout for any country in the world is available to purchasers of the report.

All report data is available in Excel format on request.

Make investment decisions and valuations with confidence using the latest data.

Table of Contents

1. Market Guides

  • 1.1. Strategic Situation Analysis
  • 1.2. Guide for Executives, Marketing, Sales and Business Development Staff
  • 1.3. Guide for Management Consultants and Investment Advisors

2. Introduction and Market Definition

  • 2.1. The New Demand for Clinical Testing
  • 2.2. Defining the Opportunity
    • 2.2.1. Revenue Market Size
  • 2.3. Methodology
    • 2.3.1. Methodology
    • 2.3.2. Sources
    • 2.3.3. Authors
  • 2.4. Perspective: Healthcare and the IVD Industry
    • 2.4.1. Global Healthcare Spending
    • 2.4.2. Spending on Diagnostics
    • 2.4.3. Important Role of Insurance for Diagnostics

3. Overview of a Dynamic Market

  • 3.1. Players in a Dynamic Market
    • 3.1.1. Academic Research Lab
    • 3.1.2. Diagnostic Test Developer
    • 3.1.3. Instrumentation Supplier
    • 3.1.4. Chemical/Reagent Supplier
    • 3.1.5. Pathology Supplier
    • 3.1.6. Independent Clinical Laboratory
    • 3.1.7. Public National/regional Laboratory
    • 3.1.8. Hospital Laboratory
    • 3.1.9. Physicians Office Lab (POLS)
    • 3.1.10. Audit Body
    • 3.1.11. Certification Body
  • 3.2. Segmentation - Different Approaches
    • 3.2.1. Traditional Market Segmentation
    • 3.2.2. Laboratory Focus and Segmentation
  • 3.3. Structure of Clinical Testing Industry
    • 3.3.1. The Hospital Lab - Share of the Pie
    • 3.3.2. Key Role for Economies of Scale
    • 3.3.3. Physician Office Lab's are Still Here
    • 3.3.4. Physician's and POCT - Reviving Patient Service in China
  • 3.4. National and Regional Diversity

4. Trends Driving a Changing Market

  • 4.1. Growth Is Pushed from Many Sides
    • 4.1.1. Demographic Impacts on Consumption
    • 4.1.2. COVID Related Impacts
    • 4.1.3. Point of Care Testing Makes a Difference
    • 4.1.4. Alternative Medicine Effect
    • 4.1.5. Esoterics
    • 4.1.6. A New Laboratory Discipline
  • 4.2. Factors at Work to Shrink the Market
    • 4.2.1. Where are Costs Going?
    • 4.2.2. Population Effects
    • 4.2.3. Management Practices
    • 4.2.4. Wellness
    • 4.2.5. Cannabilization
    • 4.2.6. Point of Care
  • 4.3. Automation and Laboratory Trends
    • 4.3.1. Traditional Automation and Centralization
    • 4.3.2. The New Automation, Decentralization and Point Of Care
    • 4.3.3. Instruments Key to Market Share
    • 4.3.4. Bioinformatics Plays a Role
    • 4.3.5. PCR Takes Command
    • 4.3.6. Next Generation Sequencing Fuels a Revolution
    • 4.3.7. NGS Impact on Pricing
    • 4.3.8. Whole Genome Sequencing, A Brave New World
    • 4.3.9. Companion Diagnostics Blurs Diagnosis and Treatment
    • 4.3.10. Shifting Role of Diagnostics

5. Clinical Laboratory Services Recent Developments

  • 5.1. Recent Developments - Importance and How to Use This Section
    • 5.1.1. Importance of These Developments
    • 5.1.2. How to Use This Section
  • 5.2. Source Bioscience Acquires Cambridge Clinical Labs
  • 5.3. Labcorp Acquires Select Assets of BioReference Health
  • 5.4. hc1 + Accumen Launches Clinical Excellence Solutions
  • 5.5. Labcorp enters lab management, services agreement with Inspira Health
  • 5.6. Aventa Genomics Receives Favorable Pricing Determination
  • 5.7. Perseus Completes Acquisition of Matrix Sistemas e Servicos Ltda
  • 5.8. Delve Bio Announces Partnership with Broad Clinical Labs for mNGS
  • 5.9. Quest Dx to Acquire Select Lab Assets from Allina Health
  • 5.10. Eurofins buys Ascend Clinical LLC
  • 5.11. Atalan Sees Potential in Hospital Outreach Business
  • 5.12. Challenge Bringing Routine Testing to Point of Care
  • 5.13. Natera Cites Test Volume Growth, Rosy Reimbursement
  • 5.14. Patients Becoming Stakeholders in Infectious Disease Testing
  • 5.15. MedGenome Acquires Prognosis Laboratories
  • 5.16. Brooks Automation acquires Aim Lab
  • 5.17. Avalon GloboCare Announces Strategic Investment in Laboratory Services MSO
  • 5.18. Mayo Clinic Laboratories and Helix to provide Biopharma Services
  • 5.19. CompuGroup Medical acquires Medicus Laboratory Information Systems
  • 5.20. Quest Diagnostics acquires Summa Health outreach lab
  • 5.21. Q2 Solutions Launches Self-Collection Safety Lab Panel
  • 5.22. Bionano Genomics Announces Launch of Bionano Laboratories
  • 5.23. Labcorp to Spin Off Clinical Development Business
  • 5.24. Value-Based Care Growing More Profitable for Labs
  • 5.25. Lucid Diagnostics Reports Revenue Growth
  • 5.26. NGS Cancer Testing Decision Appeases Industry
  • 5.27. Clinical Labs Make Strong Showing in 2021
  • 5.28. Seegene to Enter Syndromic MDx Space
  • 5.29. EKF Diagnostics Acquires Advanced Diagnostic Laboratory
  • 5.30. Molecular Health, EDGC Ink Liquid Biopsy Partnership
  • 5.31. ProPhase Labs Acquires Nebula Genomics for $14.6M
  • 5.32. Karius Cell-Free DNA Method to Detect Infection Validated
  • 5.33. EDGC Enters Liquid Biopsy Space With Cf DNA
  • 5.34. TruDiagnostic Receives CLIA Certification for Kentucky Laboratory
  • 5.35. Enzo Biochem Q2 Revenues Up 62 Percent
  • 5.36. Thermo Fisher Gets CE Mark for High-Throughput COVID-19 Assay
  • 5.37. FDA Issues Alert - False Negatives due to SARS-CoV-2 Mutations
  • 5.38. Will Labs Use Expanded Molecular Testing Capacities Post-COVID-19?
  • 5.39. Chinese Infectious Dx Firm Vision Medicals Completes Series B Financing
  • 5.40. Cooperative Aims to Expand Clinical, Commercial NGS Access

6. Profiles of Key Companies

  • 6.1. Accel Diagnostics
  • 6.2. Acibadem Labmed Laboratory
  • 6.3. ACM Medical Laboratory
  • 6.4. Adicon Clinical Laboratories
  • 6.5. Aegis Science Corporation
  • 6.6. American Bio-Clinical Laboratories, Int'l
  • 6.7. ARUP Laboratories
  • 6.8. Ascend Clinical
  • 6.9. Bio-Reference Laboratories
  • 6.10. Bioscientia Institut fur Medizinische Diagnostik GmbH
  • 6.11. BP Healthcare Group
  • 6.12. C2N Diagnostics
  • 6.13. Clinical Reference Laboratory
  • 6.14. Clongen Laboratories
  • 6.15. CompuNet Clinical Laboratories
  • 6.16. DASA
  • 6.17. DIAN Diagnostics Co., Ltd.
  • 6.18. Enzo Biochem
  • 6.19. Eone Laboratories
  • 6.20. Eurofins Scientific
  • 6.21. Exagen Diagnostics
  • 6.22. Flow Health
  • 6.23. Fyr Diagnostics
  • 6.24. Genzyme Corporation
  • 6.25. Guangzhou Kingmed Diagnostics Group Co., Ltd.
  • 6.26. Haystack Oncology (Quest Dx)
  • 6.27. Innoquest Pathology
  • 6.28. Integrated Regional Laboratories
  • 6.29. KDL Group
  • 6.30. Laboratory Corporation of America
  • 6.31. Lifelabs (Quest)
  • 6.32. Mayo Clinic Laboratories
  • 6.33. Medicover
  • 6.34. Myriad Genetics
  • 6.35. NeoGenomics
  • 6.36. OncoDNA
  • 6.37. Oncohost
  • 6.38. Prometheus Laboratories
  • 6.39. ProPhase Labs
  • 6.40. Psychemedics Corporation
  • 6.41. Quest Diagnostics
  • 6.42. SkylineDx
  • 6.43. Sonic Healthcare
  • 6.44. Sophia Genetics
  • 6.45. Spectra Laboratories
  • 6.46. Streamline Scientific
  • 6.47. Synlab
  • 6.48. Sysmex Inostics
  • 6.49. Unilabs
  • 6.50. Werfen

7. The Global Market for Clinical Laboratory Testing

  • 7.1. Global Market Overview by Country
    • 7.1.1. Table - Global Market by Country
    • 7.1.2. Chart - Global Market by Country
  • 7.2. Global Market by Assay Type - Overview
    • 7.2.1. Table - Global Market by Assay Type
    • 7.2.2. Chart - Global Market by Assay Type - Base/Final Year Comparison
    • 7.2.3. Chart - Global Market by Assay Type - Base Year
    • 7.2.4. Chart - Global Market by Assay Type - End Year
    • 7.2.5. Chart - Global Market by Assay Type - Share by Year
    • 7.2.6. Chart - Global Market by Assay Type - Segments Growth
  • 7.3. Global Market by Place - Overview
    • 7.3.1. Table - Global Market by Place
    • 7.3.2. Chart - Global Market by Place - Base/Final Year Comparison
    • 7.3.3. Chart - Global Market by Place - Base Year
    • 7.3.4. Chart - Global Market by Place - End Year
    • 7.3.5. Chart - Global Market by Place - Share by Year
    • 7.3.6. Chart - Global Market by Place - Segments Growth
  • 7.4. Global Market by Product - Overview
    • 7.4.1. Table - Global Market by Product
    • 7.4.2. Chart - Global Market by Product - Base/Final Year Comparison
    • 7.4.3. Chart - Global Market by Product - Base Year
    • 7.4.4. Chart - Global Market by Product - End Year
    • 7.4.5. Chart - Global Market by Product - Share by Year
    • 7.4.6. Chart - Global Market by Product - Segments Growth

8. Global Clinical Laboratory Diagnostic Markets - By Assay Type

  • 8.1. Chemistry
    • 8.1.1. Table Chemistry - by Country
    • 8.1.2. Chart - Chemistry Growth
  • 8.2. Microbiology
    • 8.2.1. Table Microbiology - by Country
    • 8.2.2. Chart - Microbiology Growth
  • 8.3. Hematology
    • 8.3.1. Table Hematology - by Country
    • 8.3.2. Chart - Hematology Growth
  • 8.4. Anatomic Pathology
    • 8.4.1. Table Anatomic Pathology - by Country
    • 8.4.2. Chart - Anatomic Pathology Growth
  • 8.5. Molecular Diagnostics
    • 8.5.1. Table Molecular Diagnostics - by Country
    • 8.5.2. Chart - Molecular Diagnostics Growth
  • 8.6. Esoteric
    • 8.6.1. Table Esoteric - by Country
    • 8.6.2. Chart - Esoteric Growth

9. Global Clinical Laboratory Diagnostic Markets - By Place

  • 9.1. In Patient Hospital
    • 9.1.1. Table In Patient Hospital - by Country
    • 9.1.2. Chart - In Patient Hospital Growth
  • 9.2. Out Patient Hospital
    • 9.2.1. Table Out Patient Hospital - by Country
    • 9.2.2. Chart - Out Patient Hospital Growth
  • 9.3. Independent Laboratory
    • 9.3.1. Table Independent Laboratory - by Country
    • 9.3.2. Chart - Independent Laboratory Growth
  • 9.4. Physicians Office Laboratory
    • 9.4.1. Table Physicians Office Laboratory - by Country
    • 9.4.2. Chart - Physicians Office Laboratory Growth
  • 9.5. Other Laboratory
    • 9.5.1. Table Other Laboratory - by Country
    • 9.5.2. Chart - Other Laboratory Growth

10. Global Clinical Laboratory Diagnostic Markets - By Product

  • 10.1. Instruments
    • 10.1.1. Table Instruments - by Country
    • 10.1.2. Chart - Instruments Growth
  • 10.2. Reagents
    • 10.2.1. Table Reagents - by Country
    • 10.2.2. Chart - Reagents Growth
  • 10.3. Labour
    • 10.3.1. Table Labour - by Country
    • 10.3.2. Chart - Labour Growth
  • 10.4. Overhead
    • 10.4.1. Table Overhead - by Country
    • 10.4.2. Chart - Overhead Growth
  • 10.5. Other Product
    • 10.5.1. Table Other Product - by Country
    • 10.5.2. Chart - Other Product Growth

11. The Future of the Clinical Laboratory

12. Appendices

  • 12.1. United States Medicare System: Clinical Laboratory Fees Schedule
  • 12.2. The Most Used IVD Assays
  • 12.3. The Highest Grossing Assays

Table of Tables

  • Table 1: Market Players by Type
  • Table 2: Clinical Laboratory Departments and Segments
  • Table 3: Laboratory Management Focus - Different Approaches
  • Table 4: Key Segmentation Variables Going Forward
  • Table 5: Factors Affecting Local Clinical Testing Demand
  • Table 6: Seven Factors Driving Growth
  • Table 7: Alternative Medicine Segments
  • Table 8: Six Factors Limiting Growth
  • Table 9: Seven Key Diagnostic Laboratory Technology Trends
  • Table 10: Global Market by Region
  • Table 11: Global Market by Assay Type
  • Table 12: Global Market by Place
  • Table 13: Global Market by Product
  • Table 14: Chemistry by Country
  • Table 15: Microbiology by Country
  • Table 16: Hematology by Country
  • Table 17: Anatomic Pathology by Country
  • Table 18: Molecular Diagnostics by Country
  • Table 19: Esoteric by Country
  • Table 20: In Patient Hospital by Country
  • Table 21: Out Patient Hospital by Country
  • Table 22: Independent Laboratory by Country
  • Table 23: Physicians Office Laboratory by Country
  • Table 24: Other Laboratory by Country
  • Table 25: Instruments by Country
  • Table 26: Reagents by Country
  • Table 27: Labour by Country
  • Table 28: Overhead by Country
  • Table 29: Other Product by Country
  • Table 30: Clinical Lab Fee Schedule
  • Table 31: The Most Common Assays
  • Table 32: Largest Revenue Assays

Table of Figures

  • Figure 1: Global Healthcare Spending
  • Figure 2: The Road to Diagnostics
  • Figure 3: The Changing Age of The World's Population
  • Figure 4: Health Care Consumption by Age
  • Figure 5: Cancer Incidence - Age at Diagnosis
  • Figure 6: Centralized vs. Decentralized Laboratory Service
  • Figure 7: A Highly Multiplexed Syndromic Testing Unit
  • Figure 8: The Real Cost to Sequence the Human Genome
  • Figure 9: The Codevelopment Process
  • Figure 10: Comparing MDx Diagnostic and Traditional Testing
  • Figure 11: Global Market Pareto Chart
  • Figure 12: Global Market by Assay Type - Base vs. Final
  • Figure 13: Global Market by Assay Type Base Year
  • Figure 14: Global Market by Assay Type End Year
  • Figure 15: Assay Type Share by Year
  • Figure 16: Assay Type Segments Growth
  • Figure 17: Global Market by Place - Base vs. Final
  • Figure 18: Global Market by Place Base Year
  • Figure 19: Global Market by Place End Year
  • Figure 20: Place Share by Year
  • Figure 21: Place Segments Growth
  • Figure 22: Global Market by Product - Base vs. Final
  • Figure 23: Global Market by Product Base Year
  • Figure 24: Global Market by Product End Year
  • Figure 25: Product Share by Year
  • Figure 26: Product Segments Growth
  • Figure 27: Chemistry Growth
  • Figure 28: Microbiology Growth
  • Figure 29: Hematology Growth
  • Figure 30: Anatomic Pathology Growth
  • Figure 31: Molecular Diagnostics Growth
  • Figure 32: Esoteric Growth
  • Figure 33: In Patient Hospital Growth
  • Figure 34: Out Patient Hospital Growth
  • Figure 35: Independent Laboratory Growth
  • Figure 36: Physicians Office Laboratory Growth
  • Figure 37: Other Laboratory Growth
  • Figure 38: Instruments Growth
  • Figure 39: Reagents Growth
  • Figure 40: Labour Growth
  • Figure 41: Overhead Growth
  • Figure 42: Other Product Growth